In this Researcher Update you’ll find information on:
- Final Reminder to RSVP for CURE Epilepsy’s Reception on December 4th at the AES Annual Meeting in Nashville
- Letter of Intent Submissions Open Today for CURE Epilepsy’s 2023 Taking Flight and CURE Epilepsy Awards
- The Pershing Square Foundation Launches the MIND (“Maximizing Innovation in Neuroscience Discovery”) Prize
- SUDEP Research Funding Opportunity for Early Career Scientists
- Apply Now for the Sergievsky Award for Epilepsy Health Equity and Diversity
- Funding Opportunity with Burroughs Wellcome Fund (BWF) Innovation in Regulatory Science Awards (IRSA)
- Register for the NIH and NINDS Workshop “Status Epilepticus after Benzodiazepines: Seizures and Improving Long-Term Outcomes”
Final Reminder to RSVP for CURE Epilepsy’s Reception on December 4th at the AES Meeting in Nashville
RSVP now to join CURE Epilepsy leadership and fellow dedicated researchers in honoring our newest grantees during our reception on December 4th at the 2022 American Epilepsy Society Annual Meeting. Light refreshments will be served.
The reception will be held:
- Sunday, December 4, 2022 @ 6:00 pm – 7:30 pm CT
- Location: Omni Nashville Hotel, 250 Rep. John Lewis Way South, Nashville
- Room: Legends A/B (Level 2)
We look forward to seeing you all!
Please note, this is not an official event of the 2022 AES Annual Meeting, nor is it sponsored or endorsed by AES
Letter of Intent Submissions Open Today for CURE Epilepsy’s 2023 Taking Flight and CURE Epilepsy Awards
Submit your Letter of Intent for our Taking Flight and CURE Epilepsy awards starting today. All Letters of Intent are due by Tuesday, January 10, 2023, at 9 pm ET.
The Taking Flight Award seeks to promote the careers of young epilepsy investigators to allow them to develop a research focus independent of their mentor(s).
The CURE Epilepsy Award reflects CURE Epilepsy’s continued focus on scientific advances that have the potential to truly transform the lives of those affected by epilepsy, with prevention and disease modification as critical goals.
Key priority areas for both awards include: 1) basic mechanisms of epilepsy, 2) acquired epilepsies, 3) pediatric epilepsies, 4) SUDEP, 5) treatment-resistant epilepsies, and 6) sleep and epilepsy.
We look forward to seeing your submissions!
The Pershing Square Foundation Launches the MIND (“Maximizing Innovation in Neuroscience Discovery”) Prize
With the launch of the MIND Prize, The Pershing Square Foundation strives to change the paradigm of neuroscience research by creating a community of next-frontier thinkers who can uncover a deeper understanding of the brain and cognition. Breakthroughs in basic scientific and translational research will yield critical tools for and knowledge of neurodegenerative diseases, including Alzheimer’s disease and dementia. The MIND Prize will bring together the most talented early-to-mid-career investigators across scientific fields with creative and experimental ideas to solve problems that will transform the current understanding of the brain and its impact on human health. The deadline to submit Letters of Intent is Monday, December 12, 2022.
SUDEP Research Funding Opportunity for Early Career Scientists
PAME (Partners Against Mortality in Epilepsy) is partnering with the American Epilepsy Society (AES) to fund ideas that advance SUDEP Summit priorities through the AES Early Career Grants program. Trainees, fellows, and newly independent investigators are encouraged to apply to any of the eight funding opportunities available. Specifically, PAME is interested in funding projects to advance priorities that will impact SUDEP prevention in the next 5 years. Applications are due Thursday, January 12, 2023.
Apply Now for a Postdoctoral Diversity Enrichment Program (PDEP)
The Sergievsky Award for Epilepsy Health Equity and Diversity provides support for early career physicians and scientists who identify as members of underrepresented racial and ethnic groups, and/or who are researching issues that affect medically underserved individuals with epilepsy or seizures or related aspects of health equity. Proposals are due Thursday, January 12, 2023.
Funding Opportunity with Burroughs Wellcome Fund (BWF) Innovation in Regulatory Science Awards (IRSA)
BWF’s Innovation in Regulatory Science Awards provides up to $500,000 over five years to academic investigators developing new methodologies or innovative approaches in regulatory science that will ultimately inform the regulatory decisions made by agencies such as the Food and Drug Administration. The deadline to apply is Friday, February 10, 2023.
Register for the NIH and NINDS Workshop “Status Epilepticus after Benzodiazepines: Seizures and Improving Long-Term Outcomes”
This virtual workshop, taking place February 28 – March 1, 2023, will convene preclinical and clinical researchers as well as stakeholders to discuss and define indications of potential therapeutics needed to improve outcomes following status epilepticus. Outcomes of the workshop will include a clearer understanding of the unmet therapeutic needs and identification of key gaps in the research, increasing the potential for new therapeutics development.